We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Forgotten Vital Stain Identifies Resistant TB

By LabMedica International staff writers
Posted on 14 Aug 2012
Print article
Image: Result of an FDA-test under the microscope: the fluorescent lines are living tuberculosis bacilli, on a background of cellular debris from human sputum (Photo courtesy of ITG).
Image: Result of an FDA-test under the microscope: the fluorescent lines are living tuberculosis bacilli, on a background of cellular debris from human sputum (Photo courtesy of ITG).
Vital staining with fluorescein diacetate (FDA) stains only living Mycobacterium tuberculosis tuberculosis bacilli so that only those bacilli resistant to treatment are seen.

Scientists improved the detection of the luminous bacilli by replacing the classical fluorescence microscope with its light-emitting diode (LED) counterpart. Together with colleagues in Bangladesh, scientists at the Antwerp Institute of Tropical Medicine (Belgium) tested the approach in the field for four years. If after treatment the FDA-test was negative, in 95% of cases more elaborate tests did not find active bacilli in the patient's sputum. And if the test was positive, a resistant bacillus had been found.

Tuberculosis bacilli that have become resistant to major antibiotics are a serious threat to world health. Checking smears under the microscope is the recommended technique for TB screening, but it cannot differentiate between living and dead bacilli. Therefore, it is not possible to know whether the bacilli observed are cadavers after a successful treatment, or resistant survivors. Only if the numbers do not decrease after a long wait, you know you are dealing with a resistant strain. But all that time the patient remains contagious.

With high-tech PCR technology, one can immediately ascertain if the bacillus is from a resistant strain, but in practice and certainly in resource-limited countries, this is unfeasible. It also is impossible to cultivate every sample and then bombard it with every possible antibiotic to survey which ones still work for that individual patient.

In 1991, a tuberculosis bug in New York was found to be resistant to 11 antibiotics. Cases have been reported where every antibiotic was useless. So far, these “omniresistant” bacilli each time perished with their host before they could spread. So far, that is. The highest numbers were all registered in the former Soviet Union.

Tuberculosis bacilli that have become resistant against the major antibiotics are a serious threat to world health.

To prevent an epidemic of difficult-to-treat tuberculosis, resistant cases, which do not react to the normal treatment, need to be recognized as early as possible, and immediately treated with second-line antibiotics that still work. But the laboratory tests to identify resistant TB bugs are cumbersome––the WHO estimates that in 2009 only 11% of multiresistant cases were discovered.

The FDA staining approach of Armand Van Deun and colleagues in the field for four years is very promising especially as it can be used in low-resource countries.

Related Links:
Antwerp Institute of Tropical Medicine
World Health Organization

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.